Come up with a name for your new list and we'll add to it:
Aeson Therapeutics raised a round of funding on , . Investors include
Research Corporation Technologies.
Dehydroepiandrosterone (DHEA) may have therapeutic uses against cardiovascular disease, immune disorders, cancer and other diseases, but the hormone is a precursor of androgens and estrogens and can c…